Announced
Completed
Synopsis
Bender Analytical Holding, a Dutch venture capital firm focused on high-impact medtech innovation, leda $25m Series B investment in AMT Medical, a Netherlands-based developer of sutureless coronary artery bypass technology, with the participation of Invest-NL a private equity firm, the European Innovation Council a venture capital firm, and Oost NL, a private equity firm. “We are proud to support AMT as they work toward FDA clearance to bring their technology to the market in the U.S. This marks a key milestone in improving patient outcomes," Johan Bender, Bender Analytical Holding CEO.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealAll rights reserved. Copyright © 2025 Datasite
Seller Team (2)
Bidder Team (5)
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy